At the start of 2022, Oncotarget began publishing research papers in a continuous publishing format in yearly volumes. As of June 23, 2022, Oncotarget has published a total of 64 high-impact, oncology-focused papers within Volume 13.
Oncotarget’s Volume 13 consists of papers authored by numerous prestigious researchers and scientists from world-renowned institutions. Select papers in this Volume were chosen for inclusion in Oncotarget’s Special Collections on breast and lung cancer research.
Read the full press release - https://www.oncotarget.net/2022/06/23/oncotarget-new-oncology-focused-papers-published-in-volume-13/
Visit www.Oncotarget.com to read the latest publications in Volume 13.
About Oncotarget:
Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
Twitter – https://twitter.com/Oncotarget
Facebook – https://www.facebook.com/Oncotarget
YouTube – www.youtube.com/c/OncotargetYouTube
Instagram – https://www.instagram.com/oncotargetjrnl/
LinkedIn – https://www.linkedin.com/company/oncotarget/
Pinterest – https://www.pinterest.com/oncotarget/
LabTube – https://www.labtube.tv/channel/MTY5OA
SoundCloud – https://soundcloud.com/oncotarget
For media inquiries, please contact: media@impactjournals.com.
